公众号 / 文章中毒与环境急症消化、代谢与肾脏急症

青少年患者大量华法林过量管理

Massive warfarin overdose management in an adolescent patient.
PubMed 文献 · Clin Toxicol (Phila) · 2022-09-07
一句话结论15岁无抗凝指征青少年急性摄入华法林1000 mg后,按CHEST指南策略INR升至>11.8时才给维生素K 10 mg,INR回落,提示该策略在无抗凝指征过量者中可否外推尚不明确。

本文报告一例15岁男性无抗凝指征青少年急性摄入1000 mg华法林,就诊时仅轻度间歇头痛,头颅CT无异常,对乙酰氨基酚、水杨酸和乙醇浓度阴性。摄入约16小时INR为1.9,26小时升至3.3;咨询地区中毒中心并遵循CHEST指南,INR>10或出现出血症状前暂不给维生素K。住院第4天INR升至>11.8时口服维生素K 10 mg,第7天重复INR为2.9和3.4后转精神科。作者讨论早期给维生素K可能暂时降低INR并掩盖反弹,认为将CHEST指南外推至无抗凝指征的急性过量患者是否合理尚不明确。

要点

  • 15岁无抗凝指征男性急性摄入华法林1000 mg,约16小时INR为1.9,26小时升至3.3,住院第4天升至>11.8。
  • 地区中毒中心按CHEST指南建议:INR>10或出现出血症状前暂不给维生素K,该患者INR>11.8时口服维生素K 10 mg。
  • 作者指出病例报告显示早期给维生素K可能暂时降低INR并妨碍发现反弹,CHEST指南在无抗凝指征急性过量者中外推的风险与获益不明确。
  • 给维生素K后第7天重复INR为2.9和3.4,患者被认为稳定可转精神科。

适用人群与场景

  • 无抗凝指征的急性华法林过量患者(本例为15岁男性,既往有焦虑、抑郁、抽动秽语综合征、注意缺陷多动障碍和多物质滥用史)

诊断标准与关键阈值

  • 按CHEST指南策略,INR>10或出现出血症状时启动维生素K

处置流程与药物剂量

  • 地区中毒中心建议遵循CHEST指南:INR>10或出现出血症状前暂不给维生素K
  • 住院第4天INR>11.8时口服维生素K 10 mg
  • 住院期间监测INR,第7天重复INR为2.9和3.4后转精神科

红旗征与不能漏的情况

  • 出现出血症状(原文按CHEST指南策略以此作为启动维生素K的指征)

研究设计与关键结果

  • 病例报告:15岁男性急性摄入华法林1000 mg,约16小时INR为1.9,26小时升至3.3,住院第4天升至>11.8,口服维生素K 10 mg后第7天INR为2.9和3.4。

证据类型、等级与局限

  • 证据类型:病例报告
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为,已确立的CHEST指南用于慢性抗凝患者INR过高时的逆转,但将其外推至无抗凝指征的急性过量患者时风险与获益不明确。

指南或共识出处

  • CHEST指南(原文提及CHEST warfarin reversal guidelines)

提炼说明

  • 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Warfarin is a widely used oral anticoagulant with established reversal guidelines in the setting of a supratherapeutic international normalized ratio (INR). Limited literature exists on managing acute warfarin overdoses in patients who are not chronically anticoagulated.

CASE: A 15-year-old male, with no indication for anticoagulation, presented to a pediatric emergency department after an acute 1,000 mg warfarin ingestion. He had no significant complaints upon presentation aside from a mild intermittent headache. His past medical history was significant for anxiety, depression, Tourette syndrome, attention deficit hyperactivity disorder, and polysubstance misuse. Computed tomography of his head was unremarkable and serum acetaminophen, salicylate, and ethanol concentrations were negative. Approximately 16 h post-ingestion, his INR was 1.9 with an increase to 3.3 by 26 h. The regional poison center was consulted and recommended, consistent with the CHEST guidelines, holding treatment with vitamin K until INR was >10 or if signs or symptoms of bleeding occurred. The patient was admitted for monitoring and by hospital day (HD) #4, his INR had risen to >11.8 at which point oral vitamin K 10 mg was administered. On HD #7, the patient was deemed stable for transfer to inpatient psychiatry after repeat INRs of 2.9 and 3.4.

DISCUSSION: Case reports have demonstrated early administration of vitamin K can temporarily lower INR and prevent detection of rebound. The CHEST warfarin reversal guidelines describe the risks and benefits with respect to bleeding and thrombosis in the non-intentional overdose patient. Application and extrapolation of these guidelines to acute overdose in patients who lack an indication for anticoagulation may or may not be warranted.

CONCLUSION: While established clinical guidance exists on reversing a supratherapeutic INR in patients chronically anticoagulated with warfarin, the risks and benefits of extrapolating this approach are unclear in those who lack an indication for anticoagulation.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Setiawan A, Vohra V, Winograd EJ, et al. Massive warfarin overdose management in an adolescent patient. Clin Toxicol (Phila). 2022. PMID: 36069749. doi:10.1080/15563650.2022.2116337

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。